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Objective: Reperfusion of the limb after acute and persistent ischemia is associated with high rates of morbidity and
mortality despite complete revascularization. Although reperfusion is a prerequisite for maintaining limb function, it may
in itself cause further injury. There is experimental evidence that modification of the initial reperfusion modalities can
minimize this reperfusion injury. We hypothesized that controlled reperfusion using a simple blood bag perfusion system
reduces reperfusion injury and facilitates the return of normal function.
Methods: Fifteen consecutive patients (mean age, 80.5  5.0 years) with severe, acute lower-limb ischemia were allocated
to two treatment arms in this prospective, controlled observational study. Group I (n  8) underwent surgical
embolectomy alone, and group II (n 7) underwent surgical embolectomy plus controlled reperfusion using a simplified
perfusion system. Indication for controlled reperfusion was made by the responsible surgeon. Controlled reperfusion
consisted of a 30-minute infusion of a crystalloid reperfusion solution that was mixed with oxygenated blood (the
blood:reperfusion solution ratio was 6:1) distal to the occlusion. Duration of ischemia, postoperative amputation rate,
motor function of the ischemic limb, and pre- and postoperative serum creatine kinase levels were assessed.
Results: The duration of ischemia was 10.7  1.1 hours in group I and 19  5.2 hours in group II (P < .05). The site of
the arterial occlusion was the iliac artery in nine patients and the common femoral artery in six patients. Full recovery was
achieved in six of seven patients in group II and in only two of eight patients in group I (P < .05). There were three
in-hospital deaths in group I, and two patients underwent major amputations. No in-hospital deaths or major
amputations occurred in group II.
Conclusion: The results from this preliminary study strongly suggest the hypothesis that the results of conventional
embolectomy for acute, severe lower-limb ischemia can be improved by controlled reperfusion. To prove our preliminary
findings, a large randomized, prospective, controlled, multicenter trial, the Controlled Reperfusion of the Acutely
Ischemic Limb trial (CRAIL-Trial) is currently being conducted to prove our preliminary findings. ( J Vasc Surg 2005;
42:690-4.)Persistent and acute ischemia of the extremity, includ-
ing neurologic dysfunction of the compromised leg, is
associated with high morbidity and mortality. The most
common reasons for acute limb ischemia are embolism of
cardiac or arterial origin and in situ thrombosis of arterio-
sclerotic vessels.1 Since the late 1960s, surgical revascular-
ization with use of the Fogarty catheter primarily has been
the therapeutic gold standard. It must be emphasized that
the results of surgical therapy have not improved over the
decades.2 Even the introduction of new interventional
treatment options such as intra-arterial thrombolysis did
not reduce the high rates of mortality and amputation.3-5
Crucial in treating acute lower-limb ischemia is that
restoration of arterial blood flow, essential for limb salvage,
can further damage ischemic tissue in a phenomenon
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690known as reperfusion injury.6 Reperfusion injury and its
systemic effects on remote organs can cause severe local and
systemic complications such as renal and pulmonary fail-
ure.7-9 There is experimental evidence that modifying the
initial perfusion modalities, especially perfusion pressure
and composition of the initial perfusate, can reduce reper-
fusion injury.10
The therapeutic principle named “controlled reperfu-
sion” was first used to treat myocardial ischemia.11 Reduc-
tion of the initial reperfusion pressure is aimed at reducing
edema development, the modification of the initial reper-
fusate is aimed at counteracting the known biochemical
changes that occur with ischemia-reperfusion, such as the
break down of aerobic metabolism, metabolic acidosis, an
increase in intracellular calcium, and the development of
oxygen-derived free radicals with the onset of reperfusion.
In an animal model of acute lower-limb ischemia, local
and systemic complications were reduced by the use of
controlled reperfusion .12 The concept of controlled reper-
fusion has been successfully used in clinical practice for
treating patients with severe, prolonged lower-limb isch-
emia.13-16
All techniques described so far have required the use of
a heart-lung machine or roller pumps. We have developed a
new blood bag reperfusion system that allows the applica-
tion of controlled reperfusion on acutely ischemic limbs
with minimal technical effort.17 As yet, no prospective
study has been published to prove the beneficial effects of
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limb ischemia. We hypothesized that controlled reperfu-
sion using a simple blood bag perfusion system reduces
reperfusion injury and thus facilitates the return of normal
function.
METHODS
Study protocol. Fifteen consecutive patients present-
ing with acute and persistent severe lower-limb ischemia
were included in the study. All patients showed ischemia-
induced neurologic dysfunction (sensory, motor, or both)
of the involved leg, thus meeting the criteria for class II or
III according to the suggestions by the Society for Vascular
Surgery.18
The decision for surgical revascularization alone (group
I) or surgical revascularization plus controlled reperfusion
(group II) was made by the responsible surgeon. Because
this was a preliminary study, the decision for controlled
reperfusion was based on the surgeon’s opinion of which
patients would benefit most from a modified therapeutic
approach.
The study was conducted at a university and two aca-
demic teaching hospitals. All in-hospital deaths, major
amputations, and neurologic function of the involved ex-
tremity at discharge from the hospital were assessed as
major endpoints. Serum creatine kinase (CK) levels were
evaluated preoperative and 24 hours postoperative. The
study protocol was approved by the University of Freiburg
Ethics Committee. All patients gave written informed con-
sent.
Management of controlled reperfusion. The perfu-
sion set for applying controlled limb reperfusion consisted
of two blood bags (each capable of holding 1 liter), crystal-
loid solution, a blood line, and a reperfusion line (both
made of .25-inch polyester tubes) (Fig). Controlled limb
reperfusion was performed as follows: the common, super-
ficial, and deep femoral arteries were exposed through a
standard groin incision. After putting the arteries on vessel
loops, a standard embolectomy or thrombectomy was per-
formed using a Fogarty catheter with longitudinal or verti-
cal incision of the vessel. Before restoration of blood flow, a
10-Charrier (CH) (1 CH is equivalent to .33 mm) cannula
was inserted proximally into the iliac artery, another 10-CH
cannula was inserted distally into the femoral artery
through the same incision, and whenever possible, a third
cannula was inserted into the deep femoral artery. The
proximal cannula was connected to the blood line, and
oxygenated blood was drawn into the first blood bag where
it was mixed with the crystalloid reperfusion solution
(blood:reperfusion solution ratio, 6:1). The composition of
the crystalloid solution is given in Table I. According to the
hemodynamic status of the patient, either 600 mL or 300
mL of blood was taken every cycle.
After the blood-reperfusion solution had been trans-
ferred to the second blood bag, the reperfusion line was
connected to this second blood bag. After all air had been
expelled from the reperfusion line, controlled reperfusion
was initiated via the distal cannula. A 12-gauge cannula wasinserted into the femoral artery distal of the reperfusion
cannula for continuous pressure control. Perfusion pressure
was kept strictly 60 mm Hg. In most cases, the blood-
reperfusion solution was returned to the leg by gravity
alone. If necessary, a pressure-cuffed bag was put around
the reperfusion bag to achieve a perfusion pressure close to
60 mm Hg. Perfusion pressure was varied by changing the
height of the blood bag.
The procedure was repeated for 30 minutes. The num-
ber of cycles performed depended on the flow that could be
achieved. After removal of the cannulas, the arteriotomy
was closed with direct suture or patch-implantation, and
The blood bag perfusion system consists of two blood bags, a
crystalloid perfusion solution, and a blood line and perfusion line
(two 10-CH cannula are connected to the system).
Table I. Composition of the crystalloid reperfusion
solution
NaCl 27.27 mmol/L
THAM (pH 7.5 – 7.7) 54.02 mmol/L
Glutamate  H2O 34.27 mmol/L
Aspartate  H2O 34.0 mmol/L
Citric acid  H2O 2.41 mmol/L
Na citrate  H2O 13.41 mmol/L
NaH2PO4  H2O 2.40 mmol/L
Glucose  H2O 157.96 mmol/L
Allopurinol 7.35 mmol/L
THAM, Tromethamine (tris-hydroxymethyl aminomethane).normal blood flow was re-established.
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mean  SEM. Numeric data were compared using un-
paired Student’s t test, and the 2 test was used to compare
binomial data. P  0.05 was considered statistically signif-
icant.
RESULTS
Fifteen patients were included in the study over a
7-month period. Eight were treated with surgical embolec-
tomy alone (group I), and seven had surgical embolectomy
and controlled reperfusion (group II). The mean age was
80.5  5.0 years. The site of the arterial occlusion was the
iliac artery in eight patients and the common femoral artery
in seven patients. There were six women in group I and
three women in group II.
In the eight group I patients, five had atrial fibrillation,
and four had pre-existing occlusive arterial disease. In the
seven group II patients, three had atrial fibrillation, and
four had pre-existing occlusive arterial disease. The dura-
tion of ischemia was 10.7  1.1 hours in group I patients
and 19  2.2 hours in group II patients (P  .05).
Preoperative serum CK was 369  107.4 U/L in
group I patients and 3257  1888 U/L in group II
patients. Serum CK levels 24 hours postoperative were
1630 665U/L in group I patients and 1778 390U/L
in group II patients. The difference between pre- and
postoperative serum CK levels in each group was not sta-
tistically significant (Table II).
During the procedure, thrombus could be removed
from the occluded vessels in all patients. Back flow of blood
from the distal vessels could be achieved as a sign of
successful revascularization in all patients. Among the seven
patients treated with controlled limb reperfusion, five had
cannulation of the superficial femoral artery and the deep
femoral artery, and in two patients, only the superficial
femoral artery was cannulated. Preparation for controlled
reperfusion lasted approximately 5 minutes for cannulation
and another 5 minutes for decannulation. This resulted in
prolongation of total operating room time of approxi-
mately 40 minutes in the patients treated with controlled
reperfusion. The volume of crystalloid perfusion solution
infused was 520  132 mL.
No intraoperative deaths occurred. Among the patients
treated with surgical embolectomy alone, there were three
in-hospital deaths caused by acute mesenteric ischemia,
myocardial failure, and multiorgan failure. Among the sur-
viving patients, two underwent major amputation, and one
patient presented with paralysis of the involved leg at the
time of discharge from hospital. No in-hospital deaths
occurred among the patients treated with surgical embo-
lectomy and controlled reperfusion, and no major amputa-
tion was necessary. One patient had paralysis at the time of
discharge from the hospital. Complete functional recovery
of the involved leg was achieved in six of the seven patients
in group II but in only two of the eight patients in group I
(P  .05).DISCUSSION
Acute lower-limb ischemia is probably the most com-
mon reason for emergency admission to a vascular surgery
unit. The predominant reasons for acute limb ischemia are
embolism of cardiac or arterial (eg, aortic aneurysm with
adherent thrombus) origin and arterial in situ thrombosis
of arteriosclerotic vessels.1
Re-establishment of arterial blood flow to the compro-
mised leg is essential for limb salvage. With introduction of
the Fogarty catheter in the early 1960s, a simple surgical
technique for the revascularization of occluded vessels was
introduced into clinical practice. In combination with other
surgical techniques for revascularization, such as local
thromboendarterectomy and bypass-procedures, vascular
surgeons today have a variety of therapeutic options for
revascularization of acutely ischemic limbs. Through the
last decades, interventional treatment options such as
thrombolytic therapy have become another therapeutic
option in treating acute limb ischemia.
Despite improvements in revascularization techniques,
the results of surgical and interventional treatments have
remained unsatisfactory, with high amputation rates and
high mortality.2,19,20 The poor results of revascularization
therapy alone may be mainly due to additional reperfusion
injury.6 Reperfusion injury is descriptive of the fact that the
reperfusion of ischemic tissue, which is absolutely necessary
for tissue salvage, causes further tissue damage that in turn
can result in tissue apoptosis and necrosis. However, a
prerequisite for evaluating different reperfusion protocols is
the achievement of a complete revascularization. Even con-
trolled reperfusion will result in amputation if revascular-
ization cannot be achieved because of obliteration of distal
vessels. The therapeutic principle of controlled reperfusion
has been used successfully in treating myocardial ischemia
and has been shown to improve clinical outcome.21
Experimental studies on isolated rat hindlimbs have
shown that cellular integrity and biochemical function is
preserved after 4 hours of warm ischemia. Severe changes
occur after the onset of uncontrolled reperfusion.22 Reduc-
tion of initial reperfusion pressure alone resulted in im-
proved functional and metabolic recovery in an animal
model of myocardial ischemia.23 In an animal model of
skeletal muscle ischemia, a reduction of reperfusion blood
flow was shown to reduce edema generation and muscle
injury.24
Controlled reperfusion, with reduced reperfusion pres-
sure and modification of the initial reperfusate, can reduce
the local consequences of reperfusion injury such as deple-
tion of high-energy phosphates and local swelling. This is
accompanied by improvement in the return of contractile
function.25 The systemic complications of reperfusion,
such as release of muscle proteins and potassium into the
systemic circulation, could be reduced in an animal model
of acute lower-limb ischemia.12
By using a simple blood bag reperfusion system, as we
did in this study, two main principles of controlled limb
reperfusion—a reduction of initial reperfusion pressure and
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can be achieved in clinical practice with minimal technical
effort. As there is evidence that most additional tissue injury
caused by uncontrolled reperfusion occurs during the first
20 to 30 minutes, a 30-minute interval for controlled
reperfusion was chosen.26
Several well-known biochemical changes occur during
ischemia and reperfusion. With the onset of ischemia, aer-
obic metabolism is suspended and anaerobic metabolism is
activated. This leads to a breakdown in high-energy phos-
phates, an increase in intracellular lactate, and intracelluar
acidosis.27 The Krebs cycle loses intermediates.28 With the
start of reperfusion, the washout of lactate and protons
from the ischemic tissue leads to an increase in intracellular
calcium. An oxidative burst with the generation of oxygen-
derived free radicals occurs with the return of oxidative
metabolism.29
The crystalloid reperfusion solution is aimed to counter
these changes. Glucose is added to provide a substrate for
anaerobic metabolism and as a hyperosmolar substance to
reduce edema generation. Tromethamine is added to
buffer ischemic acidosis. With glutamate and aspartate,
amino acid precursors of the Krebs cycle are added to
ensure more effective oxidative metabolism with the onset
of reperfusion. Allopurinol is added to reduce the genera-
tion of oxygen-derived free radicals. Sodium citrate is
added to reduce intracellular calcium.
The results of this preliminary study show that con-
trolled limb reperfusion using this simplified reperfusion
system can be safely performed in any operating room.
Controlled limb reperfusion has been used before with
good results. All the techniques described so far required
Table II. Patient data
Pat. No.
Age
(yrs)
Site of
Occlusion
Duration of
ischemia (h)
Group I*
1 63 Iliac artery 16.5
2 87 Iliac artery 13
3 91 Femoral artery 8
4 83 Iliac artery 8
5 79 Femoral artery 8
6 90 Femoral artery 12
7 73 Femoral artery 8
8 79 Femoral artery 12
Mean 80.6  3.3 10.7  1.1
Group II†
1 80 Iliac artery 8
2 89 Iliac artery 12
3 92 Iliac artery 18
4 65 Femoral artery 12
5 60 Iliac artery 48
6 73 Femoral artery 12
7 72 Iliac artery 23
Mean 75.9  4.5 19.0  5.2
CK, Creatine kinase; NA, not available.
*Group I (n  8) had surgical embolectomy alone.
†Group II (n  7) had surgical embolectomy and controlled reperfusion.the use of a heart-lung machine or roller pumps.13-15 Thisrequired an enormous technical effort and limited the use
of controlled reperfusion to large vascular surgery centers.
Most patients with acute lower-limb ischemia will not
present at centers capable of providing these techniques.
A major difference between the reperfusion system
used in this study and the techniques previously described is
that our system does not include venous blood drainage of
the ischemic limb. After a period of severe ischemia, reper-
fusion of the involved leg results in the washout of large
amounts of muscular waste products into the systemic
circulation. This has been described as a part of the reper-
fusion syndrome and is associated with multiorgan failure
and death.6,30 The rationale for venous blood drainage is to
prevent metabolic waste products from entering the sys-
temic circulation. Experimental studies on isolated rat
hindlimbs showed that controlled reperfusion significantly
reduces the amount of metabolic waste products.25 On the
other hand, drainage of the venous efflux of the ischemic
leg requires enormous technical effort and may be associ-
ated with acute volume depletion.
The duration of ischemia in the patients included in this
study was rather long. The duration of ischemia was signif-
icantly longer in the controlled reperfusion group than in
the surgical embolectomy alone group, which may be ex-
plained by the fact that allocation to either of the two
treatment groups was at decision of the responsible sur-
geon. The surgeons might have believed that the patients
with extremely long periods of ischemiamight benefitmore
from controlled reperfusion. No deaths or amputations
occurred in the controlled reperfusion group, which con-
trasts with the results reported in the literature concerning
K preop
(U/L)
CK 24h post-op
(U/L) Outcome
293 209 Normal function
63 NA Death (mesenteric ischemia)
775 2972 Amputation
NA NA Death (myocardial failure)
460 395 Normal function
658 2669 Death (multiorgan failure)
14 15 Amputation
321 3522 Paralysis
69  107 1630  665
2262 2420 Normal function
2218 1015 Normal function
NA 132 Normal function
258 2002 Normal function
12456 3050 Paralysis
31 161 Normal function
2321 2017 Normal function
57  1888 1778  390C
3
32surgical treatment of acute limb ischemia. Clinical studies
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have showed good results.13-17
To our knowledge there is only one controlled pro-
spective trial that significantly differs from our study, as
there were patients with chronic as well as acute lower-limb
ischemia enrolled in this study.16 Some patients in this
study were treated with venous drainage of the ischemic
leg, which differs from our technique.
CONCLUSION
Our results strongly support the hypothesis that con-
trolled reperfusion can improve outcome after acute severe
lower-limb ischemia even though this preliminary study
was limited by the small number of patients and the fact
that allocation to the treatment groups was not random-
ized. To prove our preliminary findings in a larger number
of patients, we are currently conducting the Controlled
Reperfusion of the Acutely Ischemic Limb trial (CRAIL-
trial), a prospective, randomized, controlled, multicenter
trial.
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